Cargando…
Assessing potential surge of COVID-19 cases and the need for booster vaccine amid emerging SARS-CoV-2 variants in Indonesia: A modelling study from West Java
OBJECTIVES: Primary and booster vaccinations are crucial in COVID-19 control. This study aimed to assess the minimum booster coverage to hamper potential surge of COVID-19 cases in 2023 in Indonesia, a low-resource setting country. METHODS: We used a modified SEIR compartment model to assess differe...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10559733/ https://www.ncbi.nlm.nih.gov/pubmed/37809646 http://dx.doi.org/10.1016/j.heliyon.2023.e20009 |
_version_ | 1785117568929890304 |
---|---|
author | Nuraini, Nuning Soekotjo, Fadiya Nadhilah Alifia, Almira Sukandar, Kamal Khairudin Lestari, Bony Wiem |
author_facet | Nuraini, Nuning Soekotjo, Fadiya Nadhilah Alifia, Almira Sukandar, Kamal Khairudin Lestari, Bony Wiem |
author_sort | Nuraini, Nuning |
collection | PubMed |
description | OBJECTIVES: Primary and booster vaccinations are crucial in COVID-19 control. This study aimed to assess the minimum booster coverage to hamper potential surge of COVID-19 cases in 2023 in Indonesia, a low-resource setting country. METHODS: We used a modified SEIR compartment model to assess different scenarios in booster coverage across West Java population: 35%, 50%, and 70%. We fitted the model, then we calculated the potential active cases in 2023 if each scenario was met before 2022 ends. A heat map of predicted cases from various booster coverages and time frames was produced and matched with vaccination rate's function to determine feasible time frames. RESULTS: A minimum of 70% booster coverage in West Java is needed to reduce 90% of potential COVID-19 cases and avert possible surge in 2023. The booster doses should be distributed before February 2023 to achieve its optimum preventive effect. Delays in achieving minimum booster coverage is acceptable, but higher booster coverage will be required. CONCLUSIONS: For better COVID-19 control in Indonesia, booster vaccination is warranted, as presented by a case study in West Java. Sufficient vaccine supplies, infrastructure, and healthcare workers should be ensured to support a successful booster vaccination program. |
format | Online Article Text |
id | pubmed-10559733 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-105597332023-10-08 Assessing potential surge of COVID-19 cases and the need for booster vaccine amid emerging SARS-CoV-2 variants in Indonesia: A modelling study from West Java Nuraini, Nuning Soekotjo, Fadiya Nadhilah Alifia, Almira Sukandar, Kamal Khairudin Lestari, Bony Wiem Heliyon Research Article OBJECTIVES: Primary and booster vaccinations are crucial in COVID-19 control. This study aimed to assess the minimum booster coverage to hamper potential surge of COVID-19 cases in 2023 in Indonesia, a low-resource setting country. METHODS: We used a modified SEIR compartment model to assess different scenarios in booster coverage across West Java population: 35%, 50%, and 70%. We fitted the model, then we calculated the potential active cases in 2023 if each scenario was met before 2022 ends. A heat map of predicted cases from various booster coverages and time frames was produced and matched with vaccination rate's function to determine feasible time frames. RESULTS: A minimum of 70% booster coverage in West Java is needed to reduce 90% of potential COVID-19 cases and avert possible surge in 2023. The booster doses should be distributed before February 2023 to achieve its optimum preventive effect. Delays in achieving minimum booster coverage is acceptable, but higher booster coverage will be required. CONCLUSIONS: For better COVID-19 control in Indonesia, booster vaccination is warranted, as presented by a case study in West Java. Sufficient vaccine supplies, infrastructure, and healthcare workers should be ensured to support a successful booster vaccination program. Elsevier 2023-09-09 /pmc/articles/PMC10559733/ /pubmed/37809646 http://dx.doi.org/10.1016/j.heliyon.2023.e20009 Text en © 2023 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Research Article Nuraini, Nuning Soekotjo, Fadiya Nadhilah Alifia, Almira Sukandar, Kamal Khairudin Lestari, Bony Wiem Assessing potential surge of COVID-19 cases and the need for booster vaccine amid emerging SARS-CoV-2 variants in Indonesia: A modelling study from West Java |
title | Assessing potential surge of COVID-19 cases and the need for booster vaccine amid emerging SARS-CoV-2 variants in Indonesia: A modelling study from West Java |
title_full | Assessing potential surge of COVID-19 cases and the need for booster vaccine amid emerging SARS-CoV-2 variants in Indonesia: A modelling study from West Java |
title_fullStr | Assessing potential surge of COVID-19 cases and the need for booster vaccine amid emerging SARS-CoV-2 variants in Indonesia: A modelling study from West Java |
title_full_unstemmed | Assessing potential surge of COVID-19 cases and the need for booster vaccine amid emerging SARS-CoV-2 variants in Indonesia: A modelling study from West Java |
title_short | Assessing potential surge of COVID-19 cases and the need for booster vaccine amid emerging SARS-CoV-2 variants in Indonesia: A modelling study from West Java |
title_sort | assessing potential surge of covid-19 cases and the need for booster vaccine amid emerging sars-cov-2 variants in indonesia: a modelling study from west java |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10559733/ https://www.ncbi.nlm.nih.gov/pubmed/37809646 http://dx.doi.org/10.1016/j.heliyon.2023.e20009 |
work_keys_str_mv | AT nuraininuning assessingpotentialsurgeofcovid19casesandtheneedforboostervaccineamidemergingsarscov2variantsinindonesiaamodellingstudyfromwestjava AT soekotjofadiyanadhilah assessingpotentialsurgeofcovid19casesandtheneedforboostervaccineamidemergingsarscov2variantsinindonesiaamodellingstudyfromwestjava AT alifiaalmira assessingpotentialsurgeofcovid19casesandtheneedforboostervaccineamidemergingsarscov2variantsinindonesiaamodellingstudyfromwestjava AT sukandarkamalkhairudin assessingpotentialsurgeofcovid19casesandtheneedforboostervaccineamidemergingsarscov2variantsinindonesiaamodellingstudyfromwestjava AT lestaribonywiem assessingpotentialsurgeofcovid19casesandtheneedforboostervaccineamidemergingsarscov2variantsinindonesiaamodellingstudyfromwestjava |